QSC PHARMA GRADE
🇮🇳 India Warehouse112-Count Pack
What is Myhep 400mg (1X28) (SOFOSBUVIR / VELPATASVIR)?
Pangenotypic HCV treatment — all genotypes 1–6. Single daily tablet for 12 weeks achieves over 97% cure rates in most patient populations.
How it Works
Sofosbuvir (NS5B polymerase inhibitor) blocks viral RNA synthesis; velpatasvir (NS5A inhibitor) blocks viral replication complex assembly. Pan-genotypic dual mechanism.
Quick Specs
| Form | Oral tablets — pre-dosed |
| Active Ingredient | SOFOSBUVIR / VELPATASVIR |
| Dose per Tablet | 400MG |
| Pack Size | 112 tablets |
| Storage | Room temperature (15–25°C), cool dry place |
| Shelf Life | 2–3 years (properly stored) |
Common Side Effects
Headache, fatigue, nausea — generally mild. One of the best-tolerated antiviral regimens available.
Safety Warnings
⚠️ Rifampin/carbamazepine dramatically reduce levels — avoid. Screen for HBV before starting (reactivation risk). Check HIV antiretroviral interactions.
Shipping: 🇮🇳 India Warehouse — international delivery
